ITRIItron, Inc.

$85.61-29% 1Y

Is the price fair?

Excellent

Undemanding: modest expectations priced in, cheap against its own history, and cheap vs its sector.

3 good
What the price assumes~−4% a year

Priced for a decline (~−4% a year). The price demands less than its three-year revenue growth of 6% a year, expectations look modest.

Vs its own P/E rangecheaper than 88% of its own historyderived

Cheap vs its own history: P/E 14.3 vs a 37.2 median over 25 quarters (−61% vs median).

Vs sector (EV/EBIT)14.8×

Sector median 30.5× across 203 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Unless marked, from derived, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)better than 73% of the market
FCF yieldbetter than 85% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What ITRI's price assumes

Itron, Inc. trades at 14.3× earnings against 38.2× for the median Scientific & Technical Instruments name, cheaper than its own group.

14.3

Trailing P/E · Scientific & Technical Instruments median 38.2 · cheaper than the typical name in its group

Price / sales
1.60

Price / sales · today's price, trailing year to Jun 30, 2026

Free cash flow yield
10%

Free cash flow yield · Scientific & Technical Instruments median 4.0%

Growth the price implies
−4.3%

Growth the price implies · The price pays for −4.3% free cash flow growth a year for a decade; the business has delivered +155% a year over the last three.

Details›
Price / booktoday's price, trailing year to Jun 30, 2026
2.28
EV / EBITtoday's price, trailing year to Jun 30, 2026
14.8
EV / salestoday's price, trailing year to Jun 30, 2026
1.96
Technology median P/E459 names
37.7
Scientific & Technical Instruments median P/E18 names
38.2
Free cash flow, trailing twelve months
$385M
Market capitalisation
$3.68B
3-year revenue growth
+6.2%
3-year free cash flow growth
+155%
ITRI has re-rated away from its own history, so multiplying the old multiple by today's earnings prices a full reversal, not the business
MethodPer share
What its own history would implynot meaningful, 14.3× today against a 37.2× median
52-week range$78.02 – $138.18
Today$85.61

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.